Upcoming Login Downtime

We're updating the Biocentury.com platform login experience to make access more secure and reliable. As part of this update, logins will be temporarily unavailable on Sunday, March 16, from 4:00AM to 4:00PM GMT. We recognize the inconvenience and appreciate your understanding. Please check back after the maintenance period.

For updates, questions, or issues, please call us at +1 650-552-4224 or email us at support@biocentury.com.

BioCentury
ARTICLE | Financial News

Sofinnova Partners vet Tordjman launches Jeito with €200M first biotech fund

January 17, 2020 10:50 PM UTC

Paris-based Jeito Capital launched Monday with the €200 million ($223.1 million) close of its first fund, which the firm will invest in 15 therapeutics start-ups, primarily in Europe.

Jeito founder and CEO Rafaèle Tordjman was a managing partner at Sofinnova Partners, where she managed €1.5 billion in assets. ...

Get Unlimited Access
Continue reading with a free trial.
Or Purchase This Article